Back

Looking beyond left ventricular ejection fraction - a new multiparametric CMR score to refine the prognostic assessment of HF patients

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in heart failure: a potpourri Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Goncalo Jose Lopes da Cunha

Hospital Santa Cruz, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail
Prognostic implications of NYHA class and NT-proBNP levels in mild heart failure: a PARADIGM-HF analysis
Doctor L. Rohde (Porto Alegre, BR)
Abstract Slides Video
Presentation thumbnail
Temporal trends in first rehospitalisation for heart failure between 1997 and 2017. trends in hospitalization characteristics and prognostic impact
Doctor A. Arulmurugananthavadivel (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Stroke in patients with heart failure and reduced ejection fraction without atrial fibrillation: external validation of a risk model
Doctor T. Kondo (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Factors associated with health-related quality of life in heart failure in 23,000 patients from 40 countries: results of the global congestive heart failure research program
Doctor I. Johansson Bartolini (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in heart failure: a potpourri

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort
thumbnail
Congress Presentation
A comprehensive CMR analysis improves risk stratification in left ventricular noncompaction
thumbnail
Congress Presentation
Cardiac magnetic resonance for prophylactic implantable-cardioVerter defibrillator therapy international registry in patients with ischemic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources